Loading page...
Log inCreate account
Loading page...
Up to €850K per project
Innovation Validation 2027 closes 13 Jan 2027The EIT's health innovation community: funding and acceleration for medtech, digital health and biotech
AI-generated cover illustration. Programme details are sourced separately below.
Dates come from the official programme and portal records shown below.
Recorded editorial check · yesterday (9 Nov 2026)
EIT Health is the European Institute of Innovation and Technology's community for health. It brings together companies, hospitals, universities and research centres and runs funding calls, accelerator programmes and education. Its EIT allocation for 2026-2028 is €67.3 million.
The call open now is Innovation Validation 2027: it opened on 14 October 2026 and closes on 13 January 2027 at 16:00 CET. It funds up to 50% of a project budget, to a maximum grant of €850,000, to take digital or AI-enabled medical devices (under MDR or IVDR) from Innovation Maturity Level 6 to 7: clinical validation, regulatory approval and market preparation. A company must lead a consortium of at least two organisations from different countries covering at least two of industry, research and education. If the commercialising company is a micro or small enterprise, it must receive €400,000 to €500,000 of the grant, and it signs a Financial Sustainability Contribution Agreement.
Most other EIT Health calls for 2026, including innovation uptake and education calls, are closed. Check the EIT Health opportunities page for the next rounds.
EIT Health money comes with strings: consortia across countries and sectors, co-funding and a financial sustainability contribution that pays some value back to EIT Health.
Register on the EU Funding & Tenders Portal (step 1 in EIT Health's instructions).
Apply through EIT Health's application platform from the Innovation Validation call page (step 2).
Join the call's open Q&A session and use the supporting pack linked from the call page.
Submit before 13 January 2027 at 16:00 CET.
Innovation Validation 2027, from 14 October 2026 to 13 January 2027 (16:00 CET), for digital and AI-enabled medical devices moving from Innovation Maturity Level 6 to 7.
Under Innovation Validation 2027, up to 50% of the project budget and at most €850,000 per project.
Not to Innovation Validation: a company must lead a consortium of at least two organisations from different countries and two sides of the knowledge triangle.
Yes. The commercialising company signs a Financial Sustainability Contribution Agreement with EIT Health.
Programme facts, dates and figures checked against the official sources on 2026-11-09.
Research updated: 2026-11-09
Official call documents take precedence. A listed reference is not necessarily indexed in full by the AI.
Read the complete text reference →A free EUACC account connects ChatGPT, Claude or Gemini to every EU programme, open call and deadline we track. Weekly call alerts are free too.
Choose your AI and follow the walkthrough. Your free EUACC account connects the two.
Illustrated walkthrough
https://www.euacc.ai/api/mcpWorks on every Claude plan, including Free (one custom connector). On Team and Enterprise, an Owner adds it.
On a phone, add it at claude.ai in your browser. It then shows up in the Claude app the next time you sign in.
Use EUACC to explore “Eit health” (https://www.euacc.ai/programmes/eit-health). Does this programme fit my startup, and what should I check before applying? Cite the available sources and flag missing or outdated information.